Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation
BMC pharmacology & toxicology - United Kingdom
doi 10.1186/2050-6511-13-s1-a14
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
Springer Science and Business Media LLC